Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Animal & Veterinary

FDA Warns of Possible Danger with Animal Vaccine Device

September 2, 2011

The Food and Drug Administration is warning veterinarians and pet owners, particularly cat owners, of the possible risk of fractures with the Vet Jet™ transdermal vaccination system device. The device, made by Bioject, Inc., is sold exclusively as the delivery system for the Merial product, PUREVAX® Recombinant Feline Leukemia Vaccine. The device delivers the leukemia vaccine through the skin to cats.

FDA is aware of three recent adverse event reports involving the use of the Vet Jet™ device in kittens. In two of the cases, the user failed or may have failed to properly lock the nozzle into the device before using it. The nozzle subsequently dislodged at the time of vaccination, causing a fracture of the femur (the thigh bone).

Merial is fully investigating the three cases. The company is also revising the “Instructions for Use” for the Vet Jet™ device to stress that users need to securely lock the nozzle into the device. In addition, Merial is sending a letter to all Vet Jet™ device users urging them to carefully follow the nozzle locking procedure.

FDA asks veterinarians and pet owners who want to report problems with the Vet Jet™ device to first contact Merial. They can also report problems to FDA by submitting FORM FDA 1932a.

Contact FDA

New! 240-402-7002
240-276-9115 FAX
Issued by: FDA, Center for Veterinary Medicine

Communications Staff, HFV-12

7519 Standish Place

Rockville, MD 20855

Page Last Updated: 01/09/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.